The research interests of Jennifer G. Le-Rademacher, Ph.D., are in the design and analysis of cancer clinical trials and statistical methodology relevant to biomedical research.
Dr. Le-Rademacher is the lead faculty statistician for the Dysproteinemia, Chronic Lymphocytic Leukemia and Myeloid Disease Oriented Groups of the Mayo Clinic Cancer Center. She is also a lead statistician for the Cancer Prevention and Control Program at Mayo Clinic.
Dr. Le-Rademacher serves as a lead statistician for the Symptom Intervention, Cancer in the Elderly, and Cancer Prevention committees of the Alliance National Cancer Institute Community Oncology Research Program (NCORP) Research Base. She collaborates with investigators in these groups on multiple cancer clinical trials and research grants.
- Symptom management and intervention
- Qualify of life
- Hematologic malignancies
- Time-to-event analysis
- Symbolic data (complex and massive data)
Significance to patient care
As a member of multidisciplinary teams, Dr. Le-Rademacher provides statistical expertise to researchers seeking novel treatments for patients with hematologic malignancies. She is also involved in research in the area of symptom management and intervention, which seeks treatments to alleviate symptoms associated with cancer therapies.